Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Evaluation of Talazoparib, A PARP Inhibitor, in Patients with Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

Breast

Breast
II
Abramson, Vandana
NCT03990896
VICCBRE2265



Phase Ib Study of Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Multiple Cancer Types

Leukemia, Myelodysplastic Syndrome, Phase I
I
Ball, Somedeb
NCT06399640
VICC-VCHEM23008P

Optimal Treatment by Invoking Biologic Clusters in Renal Cell Carcinoma (OPTIC RCC)

Kidney (Renal Cell)

Kidney (Renal Cell)
II
Rini, Brian
NCT05361720
VICCURO21103


A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor.

Multiple Cancer Types

Germ Cell (Pediatrics), Pediatrics
II
Esbenshade, Adam
NCT04684368
COGACNS2021

The Phase III Adaptive Radiation and Chemotherapy for Muscle Invasive Bladder Cancer Trial (ARCHER)

Bladder

Bladder
III
Kirschner, Austin
NCT07097142
NRGUROGU015

A Phase I Trial Combining Triapine with Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Neuro-Oncology

Neuro-Oncology
I
Merrell, Ryan
NCT06860594
VICC-NTNEU24156P

Optimice-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve PCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy

Breast

Breast
III
Abramson, Vandana
NCT05812807
VICC-NTBRE23357

Clinical Trials Search CTA Inline Referral Form

To learn more about any of our clinical
trials, call 615-936-8422.